Proteomics of bronchial biopsies: Galectin-3 as a predictive biomarker of airway remodelling modulation in omalizumab-treated severe asthma patientsPierluigi Mauri, Giorgio Walter Canonica, A Riccio et al.|Immunology Letters|2014Cited by 101
Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 monthsA Riccio, Giorgio Walter Canonica, Rossana Rossi et al.|Clinical and Translational Allergy|2017Cited by 73
Plasma Galectin-3 and urine proteomics predict FEV1 improvement in omalizumab-treated patients with severe allergic asthma: Results from the PROXIMA sub-studyA Riccio, Giorgio Walter Canonica, Pierluigi Mauri et al.|World Allergy Organization Journal|2020Cited by 23
Poster 1002: Galectin-3 as predictive biomarker of airways remodeling modulation in omalizumab treated severe asthma patientsPierluigi Mauri, Giorgio Walter Canonica, A Riccio et al.|World Allergy Organization Journal|2014Cited by 4
MOESM2 of Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36Â monthsA Riccio, Giorgio Walter Canonica, Pierluigi Mauri et al.|Figshare|2017Cited by 0